US Edition'Ireland was very smart' - Trump cites pharma tariffs
- In March 2025, US President Donald Trump announced the US would introduce tariffs on pharmaceuticals, potentially targeting countries like Ireland, where many pharmaceutical products are manufactured, to bring the pharmaceutical industry back to the US.
- Trump's decision stems from a belief that the US does not sufficiently produce its own medical drugs and aims to address what he views as unfair tax practices benefiting countries like Ireland, a concern echoed by Howard Lutnick's claim that Ireland holds significant US pharmaceutical intellectual property.
- The proposed tariffs, potentially at 25% or higher, extend beyond pharmaceuticals, with Trump threatening larger tariffs on the European Union and Canada if they economically harm the US, mirroring a broader trade war strategy.
- Trump stated, "It's in other countries, largely made in China, a lot of it made in Ireland. But we're going to have that," and accused the Irish government of "taking" US pharmaceutical companies, while also claiming, "All of a sudden Ireland has our pharmaceutical companies, this beautiful island of five million people has got the entire US pharmaceutical industry in its grasps."
- Experts like Ibec Chief Executive Danny McCoy and the ESRI warn that these tariffs could negatively impact consumers, voters, and Ireland's corporate tax revenue, particularly from pharmaceutical companies, which contributed €28bn in Irish corporate tax last year, while also potentially damaging the US's reputation as a reliable economic partner.
Insights by Ground AI
Does this summary seem wrong?
11 Articles
11 Articles
All
Left
4
Center
2
Right
2
Coverage Details
Total News Sources11
Leaning Left4Leaning Right2Center2Last UpdatedBias Distribution50% Left
Bias Distribution
- 50% of the sources lean Left
50% Left
L 50%
C 25%
R 25%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
